Abstract
BACKGROUND: DNA damage in cardiomyocytes is a key pathological pathway in heart failure progression. It is a reversible process that precedes apoptosis and fibrosis. However, the utility of cardiovascular magnetic resonance T(1) mapping for assessing DNA damage is uncertain. OBJECTIVES: This study aimed to evaluate the relationship between T(1) mapping and cardiomyocyte DNA damage in patients with dilated cardiomyopathy (DCM). METHODS: We identified 36 recent-onset DCM patients undergoing endomyocardial biopsy and serial 3T cardiovascular magnetic resonance before and after guideline-directed therapy. Extracellular volume (ECV) was quantified from native and postcontrast T(1) mapping. DNA damage was assessed via poly(ADP-ribose) quantification in biopsy specimens, alongside collagen volume fraction (CVF) measurement. RESULTS: Native T(1) and ECV showed a strong correlation with histological CVF (r = 0.62 and r = 0.67, respectively; P < 0.001), while native T(1) moderately correlated with the severity of cardiomyocyte DNA damage (r = 0.41, P = 0.01), but ECV did not. This association remained significant after controlling for CVF. Patients with substantial DNA damage have significantly higher native T(1) for an equivalent ECV (P = 0.004). In the absence of severe fibrosis, myocardial tissue recovery following guideline-directed therapy, along with improvements in left ventricular ejection fraction and reductions in left ventricular cavities, was associated with baseline DNA damage (r = -0.49, P = 0.004) but not with CVF (r = -0.17, P = 0.38). CONCLUSIONS: Native T(1) mapping effectively detects DNA damage and fibrosis, revealing different pathophysiological mechanisms behind the increased native T(1) and ECV. A disproportionate increase in native T(1) relative to ECV suggests early myocardial injury preceding fibrosis in DCM, with potential implications for myocardial tissue recovery after guideline-directed therapy.